Ausgabe 3/2019
Inhalt (12 Artikel)
An EU-wide approach to HTA: An irrelevant development or an opportunity not to be missed?
Panos Kanavos, Aris Angelis, Michael Drummond
Long-term medical costs of Alzheimer’s disease: matched cohort analysis
Elizaveta Sopina, Eldon Spackman, Janne Martikainen, Gunhild Waldemar, Jan Sørensen
Determinants of time to institutionalisation and related healthcare and societal costs in a community-based cohort of patients with Alzheimer’s disease dementia
Mark Belger, Josep Maria Haro, Catherine Reed, Michael Happich, Josep Maria Argimon, Giuseppe Bruno, Richard Dodel, Roy W. Jones, Bruno Vellas, Anders Wimo
Harsh times: do stressors lead to labor market losses?
Terhi Maczulskij, Petri Böckerman
The impact of long-term care on primary care doctor consultations for people over 75 years
Julien Forder, Katerina Gousia, Eirini-Christina Saloniki
Impact of late and prolonged working life on subjective health: the Swedish experience
Dominique Anxo, Thomas Ericson, Chizheng Miao
Cost-effectiveness of controlling gestational diabetes mellitus: a systematic review
Najmiatul Fitria, Antoinette D. I. van Asselt, Maarten J. Postma
A QALY loss is a QALY loss is a QALY loss: a note on independence of loss aversion from health states
Stefan A. Lipman, Werner B. F. Brouwer, Arthur E. Attema
Advanced therapy medicinal products and health technology assessment principles and practices for value-based and sustainable healthcare
Bengt Jönsson, Grace Hampson, Jonathan Michaels, Adrian Towse, J.-Matthias Graf von der Schulenburg, Olivier Wong
Alcohol quantity and quality price elasticities: quantile regression estimates
Robert Pryce, Bruce Hollingsworth, Ian Walker
Do political factors influence public health expenditures? Evidence pre- and post-great recession
Héctor Bellido, Lorena Olmos, Juan Antonio Román-Aso
Stratified treatment recommendation or one-size-fits-all? A health economic insight based on graphical exploration
Qi Cao, Erik Buskens, Hans L. Hillege, Tiny Jaarsma, Maarten Postma, Douwe Postmus